Neuracle Science Co., Ltd.

Anygen Co., Ltd.

Jong-Ik Hwang

Dong-Hoon Kim

Jae Young Seong

Gi Hoon Son

Yoo-Na Lee

Seongsik Yun

Arfaxad Reyes-Alcaraz

Hyun Kyung Kim

Kyung-jin Kim

Dong-Gyu Kim

Jae-Young Seong

Se-Hyung Cho

Gi-Hoon Son

The present invention relates to spexin-based agonists specific for galanin receptor type 2 and use thereof. More specifically, the present invention provides peptide-based agonists with high specificity for galanin receptor type 2 and improved stability. The peptide-based agonists are involved in the regulation of in vivo physiological functions, such as food intake, anxiety, emotion, and addiction, for which galanin receptors type 2 is responsible, to effectively suppress appetite, help recover from anxiety disorder, and reduce pleasure addiction. Therefore, the peptide-based agonists can be used to prevent or treat galanin receptor type 2-mediated diseases.

Agonist of spexin-based galanin type 2 receptor and use thereof

The present invention relates to a composition for regulating circadian rhythms, a composition for diagnosing circadian rhythm disorders and a diagnostic kit, wherein the composition for regulating circadian rhythms comprises NQ peptides, C12orf39 genes, NQ peptides cDNA and the like, which relate to circadian regulation in vertebrates as main components.

Method for regulating circadian rhythms

Growing community of inventors

Seoul, South Korea

Jong-Ik Hwang